161 related articles for article (PubMed ID: 17995585)
1. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.
Ueda S; Yamagishi S; Kaida Y; Okuda S
Nephrology (Carlton); 2007 Dec; 12(6):582-90. PubMed ID: 17995585
[TBL] [Abstract][Full Text] [Related]
2. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
[TBL] [Abstract][Full Text] [Related]
4. New pathways to renal damage: role of ADMA in retarding renal disease progression.
Ueda S; Yamagishi S; Okuda S
J Nephrol; 2010; 23(4):377-86. PubMed ID: 20349427
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
Zoccali C; Kielstein JT
Curr Opin Nephrol Hypertens; 2006 May; 15(3):314-20. PubMed ID: 16609301
[TBL] [Abstract][Full Text] [Related]
6. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
Gilinskiĭ MA
Usp Fiziol Nauk; 2007; 38(3):21-39. PubMed ID: 17977229
[TBL] [Abstract][Full Text] [Related]
7. Role of asymmetrical dimethylarginine in the progression of renal disease.
Raptis V; Kapoulas S; Grekas D
Nephrology (Carlton); 2013 Jan; 18(1):11-21. PubMed ID: 23016674
[TBL] [Abstract][Full Text] [Related]
8. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio.
Bode-Böger SM; Scalera F; Ignarro LJ
Pharmacol Ther; 2007 Jun; 114(3):295-306. PubMed ID: 17482266
[TBL] [Abstract][Full Text] [Related]
9. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
10. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
[TBL] [Abstract][Full Text] [Related]
11. Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
Baylis C
Nat Clin Pract Nephrol; 2006 Apr; 2(4):209-20. PubMed ID: 16932427
[TBL] [Abstract][Full Text] [Related]
12. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
13. Role of asymmetric dimethylarginine in cardiorenal syndrome.
Ueda S; Yamagishi S; Yokoro M; Okuda S
Curr Pharm Des; 2014; 20(14):2448-55. PubMed ID: 23844812
[TBL] [Abstract][Full Text] [Related]
14. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
Bai Y; Hui R
Med Hypotheses; 2008; 70(5):962-6. PubMed ID: 17983707
[TBL] [Abstract][Full Text] [Related]
15. [Methylarginies-induced endothelial dysfunction in chronic kidney disease].
Kimura K
Yakugaku Zasshi; 2012; 132(4):443-8. PubMed ID: 22465920
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role of asymmetric dimethylarginine (ADMA) in cannabinoid tolerance and dependence.
Ulugol A
Med Hypotheses; 2009 Aug; 73(2):213-4. PubMed ID: 19329260
[TBL] [Abstract][Full Text] [Related]
17. The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: role of asymmetric dimethylarginine.
Zhang Z; Zou YY; Zhou Y; Zhou H; Li YJ
J Clin Gastroenterol; 2009 Mar; 43(3):261-6. PubMed ID: 18936714
[TBL] [Abstract][Full Text] [Related]
18. Plasma asymmetric dimethylarginine and retinal vessel diameters in middle-aged men.
Hemminki V; Laakso J; Kähönen M; Turjanmaa V; Uusitalo H; Lehtimäki T; Ruokonen I; Laaksonen R; Huhtala H; Päivä H
Metabolism; 2007 Oct; 56(10):1305-10. PubMed ID: 17884437
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
Kielstein JT; Zoccali C
Am J Kidney Dis; 2005 Aug; 46(2):186-202. PubMed ID: 16112037
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
Tain YL
Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
